Pfizer has announced the successful completion of its acquisition of Array BioPharma Inc. https://lnkd.in/ebsuavF
About us
Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.
- Website
-
http://www.arraybiopharma.com
External link for Array BioPharma Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Boulder, CO
- Type
- Public Company
- Founded
- 1998
- Specialties
- Small molecule drug discovery and development., oncology, biotechnology, melanoma, and colorectal cancer
Locations
Employees at Array BioPharma Inc.
Updates
Similar pages
Browse jobs
Stock
ARRY
NASDAQ
20 minutes delay
$6.71
-0.14 (-2.044%)
- Open
- 6.9
- Low
- 6.62
- High
- 6.9
Data from Refinitiv
See more info on